Washington State House of Representatives Office of Program Research |
BILL ANALYSIS |
Appropriations Committee | |
HB 2023
This analysis was prepared by non-partisan legislative staff for the use of legislative members in
their deliberations. This analysis is not a part of the legislation nor does it constitute a
statement of legislative intent.
Brief Description: Establishing newborn screening fees.
Sponsors: Representatives Schual-Berke, Hinkle, Cody, Campbell, Darneille, Walsh, Morrell, Seaquist, Hunter, Hunt, Dunshee, Ericks, Haigh, Simpson, Ormsby and Sells.
Brief Summary of Bill |
|
Hearing Date: 2/12/07
Staff: Bernard Dean (786-7130).
Background:
Newborn infants born in Washington are screened for several inherited genetic disorders before
they are discharged from a hospital. In 2005, screenings were performed for approximately
78,000 newborns. The Department of Health (DOH) assesses a one-time charge for the
screening which is added to billings for maternity services. The current fee is $60.90 per infant.
This newborn screening fee does not cover follow-up treatment services for children.
However, the DOH is authorized to collect an additional fee to fund specialty clinics that provide
treatment services for hemoglobin diseases, phenylketonuria, congenital adrenal hyperplasia,
congenital hypothyroidism, and, during the 2005-07 fiscal biennium, other inheritable or
metabolic disorders leading to mental retardation or physical defects as defined by the state
Board of Health. The additional fee is currently set at $6.60 per infant. This includes $3.50 per
infant to replace discontinued federal grants that supported the treatment of phenylketonuria and
sickle cell disease and $3.10 per infant to help fund the cost of treatment for children diagnosed
with one of five disorders added to the newborn screening panel in 2003. The authority to collect
the $3.10 fee expires June 30, 2007.
Summary of Bill:
Newborn screening fees for supplying services in specialty clinics are set at $67.50 per infant in
statute (from $6.60) and congenital hypothyroidism is removed from the list of eligible disorders
that receive treatment funding through the fee.
Appropriation: None.
Fiscal Note: Available.
Effective Date: The bill contains an emergency clause and takes effect on July 1, 2007.